Liver dialysis device proved safe and effective for treating severe liver failure

June 13, 2023
This study is one of the first-in-human randomized, controlled clinical trial of a liver dialysis device.

A successful in-patient trial of liver dialysis has been completed by researchers from UCL, the Royal Free Hospital, UCL spin-out Yaqrit and their collaborators. 

The DIALIVE device, invented by researchers at UCL’s Institute for Liver and Digestive Health, was found to be safe and was associated with substantial improvement in the severity of symptoms and organ function in a greater proportion of patients with acute-on-chronic liver failure (ACLF), when compared with patients receiving standard of care. 

The next step will be a larger clinical trial, which if successful could see DIALIVE approved for clinical use within the next three years. 

UCL release on Newswise